linkseq suretyper ssp pcr assay (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
95
Structured Review
Thermo Fisher
linkseq suretyper ssp pcr assay
Linkseq Suretyper Ssp Pcr Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcr+ssp/Substance+P/pm41392567-52-18-23
Average 95 stars, based on 1 article reviews
Linkseq Suretyper Ssp Pcr Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcr+ssp/Substance+P/pm41392567-52-18-23
Average 95 stars, based on 1 article reviews
linkseq suretyper ssp pcr assay - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco Article Snippet: .. HLA class I typing was executed using the CDC (complement dependent cytotoxicity) technique (OneLambdaTM, Los Angeles CA, USA), and HLA class II typing was performed by either Article Title: Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases Article Snippet: .. FinnGen, Finland , 339,233 participants; mean age 54 years; 44% men , rSSO-Luminex technology (Labtype, One Lambda); Article Title: SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial. Article Snippet: Despite advances, few therapeutics have shown efficacy in severe coronavirus disease 2019 (COVID-19).. In a different context, virus-specific T cells have proven safe and effective.. We conducted a randomized (2:1), open-label, phase 1/2 trial to evaluate the safety and efficacy of off-the-shelf, partially human leukocyte antigen (HLA)-matched, convalescent donorderived severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)specific T cells (CoV-2-STs) in combination with standard of care (SoC) in patients with severe COVID-19 compared to SoC during Delta variant predominance. Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco Article Snippet: .. Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco. Article Snippet: .. HLA class I typing was executed using the CDC (complement dependent cytotoxicity) technique (OneLambdaTM, Los Angeles CA, USA), and HLA class II typing was performed by either Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco. Article Snippet: .. Article Title: Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction Article Snippet: Sequencing reaction was performed using the Illumina iSeqTM platform and results analysed on GenDx NGS engine. .. All other recipients and transplant donors were routinely typed for HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1/B3/B4/B5, and HLA‐DQB1 loci using in house Article Title: Comparative outcomes of DSA positive, crossmatch negative living donor kidney transplants versus remaining on the waitlist for an HLA compatible deceased donor. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Sequencing:Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco Article Snippet: .. HLA class I typing was executed using the CDC (complement dependent cytotoxicity) technique (OneLambdaTM, Los Angeles CA, USA), and HLA class II typing was performed by either Article Title: SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial. Article Snippet: Despite advances, few therapeutics have shown efficacy in severe coronavirus disease 2019 (COVID-19).. In a different context, virus-specific T cells have proven safe and effective.. We conducted a randomized (2:1), open-label, phase 1/2 trial to evaluate the safety and efficacy of off-the-shelf, partially human leukocyte antigen (HLA)-matched, convalescent donorderived severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)specific T cells (CoV-2-STs) in combination with standard of care (SoC) in patients with severe COVID-19 compared to SoC during Delta variant predominance. Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco. Article Snippet: .. HLA class I typing was executed using the CDC (complement dependent cytotoxicity) technique (OneLambdaTM, Los Angeles CA, USA), and HLA class II typing was performed by either Article Title: Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction Article Snippet: Sequencing reaction was performed using the Illumina iSeqTM platform and results analysed on GenDx NGS engine. .. All other recipients and transplant donors were routinely typed for HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1/B3/B4/B5, and HLA‐DQB1 loci using in house Article Title: Comparative outcomes of DSA positive, crossmatch negative living donor kidney transplants versus remaining on the waitlist for an HLA compatible deceased donor. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Amplification:Article Title: SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial. Article Snippet: Despite advances, few therapeutics have shown efficacy in severe coronavirus disease 2019 (COVID-19).. In a different context, virus-specific T cells have proven safe and effective.. We conducted a randomized (2:1), open-label, phase 1/2 trial to evaluate the safety and efficacy of off-the-shelf, partially human leukocyte antigen (HLA)-matched, convalescent donorderived severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)specific T cells (CoV-2-STs) in combination with standard of care (SoC) in patients with severe COVID-19 compared to SoC during Delta variant predominance. Next-Generation Sequencing:Article Title: SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial. Article Snippet: Despite advances, few therapeutics have shown efficacy in severe coronavirus disease 2019 (COVID-19).. In a different context, virus-specific T cells have proven safe and effective.. We conducted a randomized (2:1), open-label, phase 1/2 trial to evaluate the safety and efficacy of off-the-shelf, partially human leukocyte antigen (HLA)-matched, convalescent donorderived severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)specific T cells (CoV-2-STs) in combination with standard of care (SoC) in patients with severe COVID-19 compared to SoC during Delta variant predominance. Software:Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco Article Snippet: .. Article Title: Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco. Article Snippet: .. |